Back

P2Y12 inhibition by clopidogrel increases adverse clinical outcomes in patients undergoing transcatheter aortic valve replacement

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Valvular Heart Disease ePosters Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Kensuke Matsushita

Yokochama City University Medical Centre, Yokohama (Japan)

132 More presentations in this session

Presentation thumbnail
Left atrial dynamics in the hemodynamic response during exercise in patients with asymptomatic severe aortic stenosis: a cardiopulmonary imaging study
Doctor T. Sugimoto (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Preserved Th2 lymphocytes improve prognosis of diabetic patients undergoing TAVR
Doctor J. Hoffmann (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Platelet membrane-coated nanoparticles target sclerotic aortic valves in ApoE-/- mice by multiple binding mechanisms under pathological shear stress
Doctor H. Yang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Long telomere length in circulating leukocytes is associated with monocytosis and poorer survival in patients with transcatheter aortic valve replacement
Doctor J. Hoffmann (Frankfurt, DE)
Abstract Slides
Presentation thumbnail
Longitudinal strain in patients with severe aortic regurgitation: superiority to ejection fraction for detection of myocardial dysfunction
Doctor J. Reil (Luebeck, DE)
Abstract Slides

Access the full session

Session thumbnail
Valvular Heart Disease ePosters

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources